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ABSTRACT
Abietane diterpenoids are naturally occurring plant metabolites with a broad spectrum 
of biological effects including antibacterial, antileishmanial, antitumor, antioxidant, as 
well as antiinflammatory activities. Recently, we found that some analogues of natural 
ferruginol (2) actively inhibited dengue virus 2 (DENV-2) replication. Due to the similarity 
with DENV, we envisaged that abietane diterpenoids would also be active against Zika virus 
(ZIKV). Six selected semi-synthetic abietane derivatives of (+)-dehydroabietylamine (3) 
were tested. Cytotoxicity was determined by MTT assay in Vero cells. In vitro anti-ZIKV 
(clinical isolate, IMT17) activity was evaluated by plaque assay. Interestingly, these molecules 
showed potential as anti-ZIKV agents, with EC
50
 values ranging from 0.67 to 18.57 µM, and 
cytotoxicity (CC
50
 values) from 2.56 to 35.09 µM. The 18-Oxoferruginol (8) (EC
50
 = 2.60 µM, 
SI = 13.51) and 12-nitro-N-benzoyldehydroabietylamine (9) (EC
50
= 0.67 µM, SI = 3.82) 
were the most active compounds, followed by 12-hydroxy-N-tosyldehydroabietylamine (7) 
(EC
50
 = 3.58 µM, SI = 3.20) and 12-hydroxy-N,N-phthaloyldehydroabietylamine (5) 
(EC
50
 = 7.76 µM, SI = 1.23). To the best of our knowledge, this is the first report on anti-Zika 
virus properties of abietanes.
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Zika virus (ZIKV) is an arbovirus of the Flaviviridae family, phylogenetically 
close to dengue virus and yellow fever. Zika virus is mainly transmitted by Aedes 
mosquitoes and usually causes a mild dengue-like illness that may include fever, 
cutaneous rash, malaise, headache, muscle and joint pain, and/or swollen lymph 
nodes. Neurological complications include Guillain–Barré syndrome and congenital 
malformations leading to microcephaly1. Although Zika virus outbreaks have 
declined after 2017, autochthonous transmission of ZIKV still occurs globally 
across at least 87 countries and territories, with the potential for re-emergence2. 
Since specific antiviral drugs or vaccines are not available, there is urgency in 
identifying antiviral agents, particularly new molecular scaffolds with potential 
novel mechanisms of actions.
Natural products have played a dominant role in the drug discovery efforts 
for the treatment of human diseases3. In fact, in 2015, small molecules accounted 
for 45 drugs as antivirals other than synthetic molecules or 70% overall based on 
natural products, indicating the potential of identifying new therapeutic candidates 
from natural sources3. The abietane diterpenoids are widely produced by conifers 
and plants belonging to the families Araucariaceae, Cupressaceae, Pinaceae, 
Podocarpaceae, and angiosperm species4. These natural products have a wide range 
of biological activities5. For example, dehydroabietic acid (1, DHA) (Figure 1), 
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displays not only antiulcer and antimicrobial properties, but 
also antitumor effects. Ferruginol (2) (Figure 1) was first 
isolated in 1939 and has been extensively studied because 
of intriguing chemical framework and promising biological 
properties6. Ferruginol (2) occurs in plants belonging to the 
Podocarpaceae, Cupressaceae, Lamiaceae and Verbenaceae 
families among others. This diterpene exhibited important 
bioactivities, such as antifungal and antimicrobial, miticidal, 
cardioactive, antioxidative, antileishmanial and nematicidal, 
antiulcer, and anti-SARS properties5. In addition, there are 
several reports on antimalarial activity of ferruginol (2)7. 
Recently, it has been reported that several antimalarials 
are endowed with anti-DENV and anti-ZIKV activities8. 
We have also found that some analogues derived from 
(+)-dehydroabietylamine (3) (Figure 1) of the naturally 
occurring abietane ferruginol (2) (Figure 1) were active 
against DENV-29. The 12-hydroxyabieta-8,11,13-triene 
skeleton, which is characteristic of the diterpenoid 
ferruginol (2), is therefore an interesting molecular scaffold 
for the development of novel antivirals against flaviviruses.
To explore the potential of some selected analogues of 
ferruginol (2) as antiviral candidates, and in continuation 
of our research programs to discover bioactive terpenoids, 
herein we report the evaluation of previously synthesized 
semisynthetic derivatives 4-99-11 from the commercially 
available (+)-dehydroabietylamine (3) (Figure 1) against a 
Brazilian strain of ZIKV. 
The compounds were obtained in enantiomerically pure 
form from commercially available (+)-dehydroabietylamine 
(3) (Figure1) according to our previously reported 
synthetic procedures9-11. The generated analogues are 
named as follows: 12-hydroxy-dehydroabietylamine 
(18-aminoferruginol, 4), 12-hydroxy-N,N-phthaloyl-
dehydro abietylamine (5), 12-acetoxy-N,N-(tetrachloro-
phthaloyl)dehydroabietylamine (6), 12-hydroxy-N-
tosyldehydroabietylamine (7), 18-oxoferruginol (8) 
and 12-nitro-N-benzoyldehydroabietylamine (9). Stock 
solutions of the tested compounds were prepared in 
dimethyl sulfoxide (DMSO) and maintained at –20 °C 
until use.
The cytotoxicity of the ferruginol analogues 4-9 
(Figure 2) was assessed on Vero cells (African green 
monkey kidney) by the MTT (3-(4,5-dimethylthiazol-
2-yl)-2,5-diphenyltetrazolium bromide) assay12. Vero 
cells suspensions (2.7 × 105 cells/mL) prepared in MEM 
(Minimal Essential Medium, Vitrocell) with 5% Fetal 
Bovine Serum (FBS, Gibco, Sao Paulo, Brazil) were 
distributed in 96-well plates (100 µL/well) and incubated 
at 37 °C (5% CO
2
) for 24 h. Then, the culture medium 
was replaced by 200 µL of two-fold serial dilutions of the 
compounds or DMSO. Cellular controls were treated with 
the culture medium only. After treatments, plates were 
further incubated at 37 °C for 4 days. Subsequently, 15 µL 
of the MTT solution (5 mg/mL) were added per well, and 
the plates were incubated again for 4 h. The MTT solution 
was removed and 100 µL of DMSO were added to dissolve 
formazan crystals. Finally, the plates were shaken and 
absorbance was read at 540 nm. The viability percentage 
data for each tested concentration of the compounds were 
entered in the GraphPad Prism software (version 5.01, San 
Diego, California, USA) to calculate the CC
50
 values, the 
concentration of compound that causes a 50% reduction in 
cell viability, through regression analysis.
Zika virus (clinical isolate, IMT17) stock was produced 
and titrated in Vero cells. The viral titer, 4.67 × 106 plaque 
forming units per milliliter (PFU/mL), was determined 
by plaque assay13. The potential anti-ZIKV activity was 
evaluated by viral plaque reduction assay. Briefly, Vero 
cells (1.5 × 105 cells/well) were grown in 24-well plates 
for 24 h. After that, cells were infected with 100 PFU/well 
and incubated for 1 h in a humidified 37 °C incubator 
with 5% CO
2
. Cells were then washed with PBS (pH 
7.0) and treated with different concentrations of each 
compound [diluted in 2 X MEM with 2% FBS and 50% 
high viscosity carboxymethyl cellulose (CMC, Sigma)]. 
Ribavirin was used as the positive control. Medium only 
and DMSO were used as untreated and solvent controls, 
respectively. After 4 days of incubation at 37 °C, 5% CO
2
, 
supernatants were removed, and cells were fixed and stained 
with 50% crystal violet in 50% ethanol. Plaque numbers 
Figure 1 - Some typical bioactive abietane-type diterpenoids.
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were used to calculate the inhibition percentage values 
in order to determine the EC
50
, the concentration of the 
compound that inhibits viral replication by 50%, through 
non-linear regression analysis using the GraphPad Prism. 





), the ratio between cytotoxicity and 
antiviral activity. 
Cytotoxicity and antiviral assay results of the 
compounds 4-9 are shown in Table 1. The 12-Nitro-N-
benzoyldehydroabietylamine (9) (EC
50
= 0.67 µM, SI = 3.82 
and EC
90
= 0.89 ± 0.004 µM) and 18-oxoferruginol (8) 
(EC
50
 = 2.60 µM, SI = 13.51 and EC
90
 = 20.79 ± 3.75 µM) 
were the most active antiviral compounds, followed 
by 12-hydroxy-N-tosyldehydroabietylamine (7) 
(EC
50
 = 3.58 µM, SI= 3.20) and 12-hydroxy-N,N-
phthaloyldehydroabietylamine (5) (EC
50
= 7.76 µM, 
SI = 1.23). 
Inhibitory values against Zika virus ranged from 0.67 
to 18.57 µM, with cytotoxicity properties varying from 
2.56 to 35.09 µM. All compounds presented EC
50
 values 
lower than the reference ribavirin (EC
50
= 98.53 µM), 
although ribavirin displayed a higher SI value (26.25). The 
resulting experimental data indicate that nitro derivative 
(9) displayed potent antiviral activity but possess a certain 
cytotoxicity. Compound 18-oxoferruginol (8) presented 
the most promising results with a higher selectivity index 
(SI = 13.51). According to Chattopadhyay et al.14 a SI of 
10 or greater is indicative of a promising antiviral activity. 
Figure 2 - Abietane analogues selected to test anti-Zika virus activity.








4 28.33±3.44 18.57±1.00 1.53
5 9.51±0.76 7.76±0.74 1.23
6 34.04±7.35 11.52±0.08 2.95
7 11.46±1.95 3.58±0.59 3.20
8 35.09±5.20 2.60±0.07 13.51
9 2.56±0.45 0.67±0.07 3.82
Ribavirin 2,586.50±318.91 98.53±6.46 26.25 
Values represent the means ± SD of at least two independent 
experiments; aCC50 = 50% cytotoxic concentration on Vero 
cells; bEC50 (μM) = 50% effective concentration against ZIKV 
replication by plaque assay; cSelectivity index (SI): ratio between 
cytotoxicity and antiviral activity (CC50/EC50).
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Therefore, it has been demonstrated that abietane-derived 
compounds represent a novel scaffold for the development 
of anti-Zika virus agents. To the best of our knowledge, this 
is the first report on anti-ZIKV activity of abietane-type 
diterpenoids. These encouraging findings warrant synthetic 
endeavors to get structure-activity relationships, as well 
as further mechanism of action and target identification 
studies.
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